Halaman 3 - Kanker paru-paru stadium 4 Dokter Terbaik - TOP-81 dokter

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Spesialis dalam viroterapi – pendekatan mutakhir untuk mengobati kanker paru-paru dengan pengalaman lebih dari 30 tahun.

• Lulus dari Institut Medis Riga
• Menjalani magang di Penyakit Dalam
• Memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins

Profesor Gül Alco berspesialisasi dalam onkologi radiasi untuk kanker paru-paru di Rumah Sakit Medipol Acibadem District.

• Pengalaman lebih dari 20 tahun di bidang onkologi radiasi
• Profesor di Universitas Istanbul Medipol
• Menempuh pendidikan di Universitas Istanbul dan Universitas Kadir Has
• Bekerja di Rumah Sakit Şişli Florence Nightingale

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Spesialis dalam onkologi bedah toraks, termasuk operasi kanker paru-paru stadium lanjut di Medical Park Göztepe Hospital Complex. Menawarkan VATS (Video Assisted Thoracoscopic Surgery) untuk prosedur minimal invasif yang presisi.

• Pengalaman luas dalam bedah kanker paru-paru dan pengobatan penyakit pleura
• Menempuh pendidikan di Universitas Paris-Sud dan Rumah Sakit Marie-Lannelongue, Prancis
• Anggota European Society of Thoracic Surgeons
• Menerbitkan berbagai makalah mengenai topik bedah toraks

Dr. Semenisity berspesialisasi dalam onkologi medis dan radioterapi di Rambam Medical Center.

• Ahli dalam pengobatan kanker paru-paru stadium lanjut
• Berfokus pada rencana terapi yang dipersonalisasi
• Bekerja dengan tim multidisiplin

Dr. Meirovitz membawa keahlian onkologi selama puluhan tahun ke Hadassah Medical Center, salah satu rumah sakit terkemuka di Israel.

• Lulus dari Fakultas Kedokteran Universitas Technion pada tahun 1990
• Spesialisasi dalam pengobatan kanker paru-paru stadium lanjut
• Praktik di Hadassah – institusi medis tingkat atas

Profesor Tamar Jablonski-Perec mengepalai Institut Onkologi di Hadassah Medical Center, dengan pelatihan dari Sloan-Kettering Cancer Center.

• Lebih dari 25 tahun memimpin program onkologi
• Spesialisasi dalam pengobatan kanker payudara dan paru-paru stadium lanjut
• Anggota komunitas riset kanker internasional
• Profesor di departemen onkologi Universitas Ibrani
• Penerima beasiswa medis Hadassah Medical School yang bergengsi

Dr. Zalmanova mengkhususkan diri dalam radioterapi untuk kanker paru-paru di Assuta Medical Center.

• Ahli radioterapi dengan fokus pada pengobatan kanker paru-paru
• Bekerja di Assuta Medical Center, fasilitas terkemuka dalam perawatan onkologi
• Berdedikasi untuk rencana perawatan yang dipersonalisasi bagi setiap pasien

Spesialis dalam bedah toraks minimal invasif untuk kanker paru-paru – Dr. Adnansayar melakukan prosedur torakoskopik dan robotik di Liv Hospital Ulus.

• Berfokus pada kanker paru-paru dan bedah trakea
• Ahli dalam transplantasi paru-paru dan bedah penyakit pleura
• Juga berpengalaman dalam bedah toraks pediatrik
• Lulusan Fakultas Kedokteran Universitas Istanbul

Penulis lebih dari 30 makalah ilmiah tentang pengobatan keganasan – Dr. Derin adalah ahli onkologi terkemuka di Rumah Sakit Liv Ulus.

• Spesialisasi dalam kanker gastrointestinal dan paru-paru
• Anggota European Society for Medical Oncology (ESMO)
• Associate Professor dengan pengalaman akademis yang luas
• Lulus dari Fakultas Kedokteran Universitas Istanbul

dr. Ece menjalani pelatihan di MD Anderson Cancer Center – salah satu rumah sakit kanker terbaik di dunia – dengan spesialisasi kanker paru-paru. Ia membawa keahlian ini ke Liv Hospital Ulus.

• Fellowship postdoctoral dalam bidang kanker paru-paru di MD Anderson
• Terlatih dalam bronkoskopi intervensional di Johns Hopkins
• Anggota Dewan Eksekutif Masyarakat Kanker Paru-paru Turki
• Menerbitkan 48 makalah penelitian internasional
• Fellow dari American College of Chest Physicians